References
- Ostad Haji E , HiemkeC , PfuhlmannB. Therapeutic drug monitoring for antidepressant drug treatment. Curr. Pharm. Des.18(36), 5818–5827 (2012).
- Hiemke C , BergemannN , ClementHWet al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry51(1–02), 9–62 (2018).
- Martial LC , AarnoutseRE , MulderMet al. Dried blood spot sampling in psychiatry: perspectives for improving therapeutic drug monitoring. Eur. Neuropsychopharmacol.27(3), 205–216 (2017).
- Denniff P , SpoonerN. Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal. Chem.86(16), 8489–8495 (2014).
- Mano Y , KitaK , KusanoK. Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, Mitra. Bioanalysis7(15), 1821–1829 (2015).
- Ye Z , GaoH. Evaluation of sample extraction methods for minimizing hematocrit effect on whole blood analysis with volumetric absorptive microsampling. Bioanalysis9(4), 349–357 (2017).
- Xie I , XuY , AndersonMet al. Extractability-mediated stability bias and hematocrit impact: high extraction recovery is critical to feasibility of volumetric adsorptive microsampling (VAMS) in regulated bioanalysis. J. Pharm. Biomed. Anal.156, 58–66 (2018).
- Kip AE , KiersKC , RosingH , SchellensJHM , BeijnenJH , DorloTPC. Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples. J. Pharm. Biomed. Anal.135, 160–166 (2017).
- De Kesel , PieterMM , LambertWE , StoveCP. Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study. Anal. Chim. Acta881, 65–73 (2015).
- Patteet L , MaudensKE , StoveCPet al. Are capillary DBS applicable for therapeutic drug monitoring of common antipsychotics?: A proof of concept. Bioanalysis7(16), 2119–2130 (2015).
- Weber J , OberfeldS , BonseA , TelgerK , LinggR , HempelG. Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC–MS. J. Pharm. Biomed. Anal.140, 347–354 (2017).
- Berm EJ , OdigieB , BijlsmaMJ , WilffertB , TouwDJ , MaringJG. A clinical validation study for application of DBS in therapeutic drug monitoring of antidepressants. Bioanalysis8(5), 413–424 (2016).
- Fabian J , LehrM. On-line dilution on-line polymer-matrix based solid phase extraction liquid chromatography mass spectrometry detection as generic system for bioanalytical investigations. J. Chromatogr. Sci. ( In press).
- Fang K , BowenCL , KellieJF , KarlinseyMZ , EvansCA. Drug monitoring by volumetric absorptive microsampling: method development considerations to mitigate hematocrit effects. Bioanalysis10(4), 241–255 (2018).
- European Medicines Agency. Guideline on Bioanalytical Method Validation (2011). https://www.ema.europa.eu/en/bioanalytical-method-validation
- US FDA. Bioanalytical Method Validation Guidance for Industry (2018).
- Antunes MV , CharaoMF , LindenR. Dried blood spots analysis with mass spectrometry: potentials and pitfalls in therapeutic drug monitoring. Clin. Biochem.49(13–14), 1035–1046 (2016).
- Matuszewski BK , ConstanzerML , Chavez-EngCM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal. Chem.75(13), 3019–3030 (2003).
- Youhnovski N , Mayrand-ProvencherL , BerubeEet al. Volumetric absorptive microsampling combined with impact-assisted extraction for hematocrit effect free assays. Bioanalysis9(22), 1761–1769 (2017).